Suppr超能文献

[继发性骨质疏松症与内科医学]

[Secondary osteoporosis and internal medicine].

作者信息

Retornaz F, Seux V, Soubeyrand J

机构信息

Service de médecine interne et gériatrie, CHRU de Marseille, hôpital Sainte-Marguerite, 270, boulevard de Sainte-Marguerite, 13327 Marseille 9, France.

出版信息

Rev Med Interne. 2004 Dec;25 Suppl 5:S543-51. doi: 10.1016/s0248-8663(04)80053-5.

Abstract

INTRODUCTION

The term 'primary' osteoporosis refers to osteoporosis that results from the involutional losses associated with aging and, in women, additional losses related to natural menopause. Osteoporosis that is caused or exacerbated by other disorders or medication exposures is referred to as 'secondary' osteoporosis.

CURRENT KNOWLEDGE AND KEY POINTS

This article describes the major causes and provides a framework for the diagnostic investigation of patients with suspected of having secondary osteoporosis. There are numerous causes of secondary bone loss, including endocrine disorders, disorders of the gastrointestinal or biliary tract, rheumatic diseases, haematological diseases, immobilization, adverse effects of drug therapy, and a wide miscellaneous group.

FUTURE PERSPECTIVES

Secondary osteoporosis is potentially reversible during the treatment of the underlying disease. It must be identified and induce a symptomatic treatment in all cases plus an etiologic treatment when possible.

摘要

引言

“原发性”骨质疏松症是指由与衰老相关的退行性骨质流失导致的骨质疏松症,在女性中,还包括与自然绝经相关的额外骨质流失。由其他疾病或药物暴露引起或加重的骨质疏松症被称为“继发性”骨质疏松症。

当前认知与要点

本文描述了主要病因,并为疑似患有继发性骨质疏松症的患者的诊断调查提供了一个框架。继发性骨质流失有多种原因,包括内分泌紊乱、胃肠道或胆道疾病、风湿性疾病、血液系统疾病、制动、药物治疗的不良反应以及一大类杂症。

未来展望

继发性骨质疏松症在基础疾病治疗期间有可能逆转。在所有病例中都必须识别并进行对症治疗,如有可能还需进行病因治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验